Literature DB >> 7683662

Kinetics of thrombin receptor cleavage on intact cells. Relation to signaling.

K Ishii1, L Hein, B Kobilka, S R Coughlin.   

Abstract

Thrombin, a protease generated at sites of vascular injury, signals cellular responses vital for hemostasis and thrombosis. How thrombin, an enzyme rather than a classical ligand, effects graded and concentration-dependent responses in its target cells has been a long-standing question. Thrombin activates its receptor by cleaving off an activation peptide to unmask a tethered peptide ligand. We utilized a thrombin receptor with an epitope-tagged activation peptide to directly demonstrate thrombin receptor cleavage and to examine the kinetics of receptor activation on intact cells. The rate of thrombin receptor cleavage was proportional to thrombin concentration over the physiologic range, but low thrombin concentrations ultimately cleaved and activated all receptors. Cumulative phosphoinositide hydrolysis in response to thrombin correlated precisely with cumulative receptor cleavage. These data strongly suggest that each cleaved and activated thrombin receptor produces a "quantum" of phosphatidylinositol hydrolysis, then shuts off. Surprisingly, this shut off occurred despite the continued presence of cleaved and "activated" receptors on the cell surface and at a time when the cells were refractory to thrombin but sensitive to agonist peptide, suggesting that a novel shut off mechanism may have evolved to deal with the tethered ligand. Unlike the case with classical ligands, cells thus cannot detect differences in thrombin concentrations as differences in fractional occupancy but rather must sense different rates of receptor activation. Because each cleaved thrombin receptor generates a quantum of second messenger, the magnitude of the cell's response to thrombin must be determined by the balance between rates of receptor activation and second messenger clearance.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7683662

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

Review 1.  How the protease thrombin talks to cells.

Authors:  S R Coughlin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

2.  Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin.

Authors:  M L Kahn; M Nakanishi-Matsui; M J Shapiro; H Ishihara; S R Coughlin
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

Review 3.  Signal transduction by protease-activated receptors.

Authors:  Unice J K Soh; Michael R Dores; Buxin Chen; JoAnn Trejo
Journal:  Br J Pharmacol       Date:  2010-05       Impact factor: 8.739

4.  Roles of protease-activated receptors in a mouse model of endotoxemia.

Authors:  Eric Camerer; Ivo Cornelissen; Hiroshi Kataoka; Daniel N Duong; Yao-Wu Zheng; Shaun R Coughlin
Journal:  Blood       Date:  2006-01-24       Impact factor: 22.113

5.  Characterization of thrombin-bound dabigatran effects on protease-activated receptor-1 expression and signaling in vitro.

Authors:  Buxin Chen; Antonio G Soto; Luisa J Coronel; Ashley Goss; Joanne van Ryn; JoAnn Trejo
Journal:  Mol Pharmacol       Date:  2015-05-01       Impact factor: 4.436

6.  Reversible and irreversible intracellular Ca2+ spiking in single isolated human platelets.

Authors:  J F Hussain; M P Mahaut-Smith
Journal:  J Physiol       Date:  1999-02-01       Impact factor: 5.182

7.  Clathrin adaptor AP2 regulates thrombin receptor constitutive internalization and endothelial cell resensitization.

Authors:  May M Paing; Christopher A Johnston; David P Siderovski; Joann Trejo
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

8.  Thrombin perturbs neurite outgrowth and induces apoptotic cell death in enriched chick spinal motoneuron cultures through caspase activation.

Authors:  V L Turgeon; E D Lloyd; S Wang; B W Festoff; L J Houenou
Journal:  J Neurosci       Date:  1998-09-01       Impact factor: 6.167

9.  Glycosylation and the activation of proteinase-activated receptor 2 (PAR(2)) by human mast cell tryptase.

Authors:  S J Compton; B Renaux; S J Wijesuriya; M D Hollenberg
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

10.  The serine protease granzyme A does not induce platelet aggregation but inhibits responses triggered by thrombin.

Authors:  H S Suidan; K J Clemetson; M Brown-Luedi; S P Niclou; J M Clemetson; J Tschopp; D Monard
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.